...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Annual Financial Reporting

"Wouldn't HL reach the majic number just by converting thus taking control of the IPs anyway?"

HL may reach 50% ownership, but the IPs will belong to all shareholders including you and me.

 

Koo

Share
New Message
Please login to post a reply